CDC-Phase I / II, multicenter, randomized and controlled clinical trial to assess the safety and efficacy of intravenous administration of Expanded Allogeneic Adipose Tissue Adult Mesenchymal Stem Cells in patients with pneumonia
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: PUBLIC ANDALUSIAN PROGRESS AND HEALTH FOUNDATION
- Phase: II
- Execution start: 21/04/2020
- End of execution: 21/04/2021
- PI: CARMEN HIDALGO TENORIO